CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 452,963	$ 457,181
Prepaid expenses	163,561	255,923
Other Current Assets	20,089
Total current assets	636,613	713,104
Property and equipment, net of accumulated depreciation	116,810	104,094
Other Assets:
Notes receivable- related party	104,268	103,242
Goodwill	0	2,458,233
Research in progress	0	7,800,000
Intangible Asset 510k License and Patents-Eye Care Division, net	4,383,873	0
Security deposit	5,000	5,000
Operating lease right-of-use asset	76,871	130,722
Total other assets	4,570,012	10,497,197
TOTAL ASSETS	5,323,435	11,314,395
Current liabilities:
Accounts payable and accrued liabilities	909,458	1,073,142
Lease liability obligations (see Note 16)	56,871	53,851
Due to shareholder	180	180
Due to first insurance funding	32,873	25,369
Promissory note (including accrued interest of $38,960 and $19,507, respectively)(see note 9)	454,693	343,725
Convertible note payable (including accrued interest of $16,919 and $0, respectively) (see note 12)	1,126,919	0
Total current liabilities	2,580,994	1,496,267
Long-term liabilities:
Deferred tax liability	0	2,340,000
Convertible note payable (including accrued interest of $209,684 and $236,148, respectively) net of unamortized debt discount of $605,640 and $843,673, respectively(see note 12)	761,604	1,676,788
Convertible note payable - related party (including accrued interest of $299,037 and $158,648, respectively)	4,299,037	4,158,648
Lease liability obligations	20,000	76,871
Total long-term liabilities	5,080,641	8,252,307
TOTAL LIABILITIES	7,661,635	9,748,574
STOCKHOLDERS' DEFICIT
Common stock, $0.0001 par value, 300,000,000 shares authorized, 138,099,981 and 125,327,579 shares issued and outstanding, respectively	13,811	12,533
Additional paid in capital	51,000,166	43,201,186
Common stock to be issued	4,530,000	201,974
Accumulated deficit	(57,882,227)	(41,849,922)
TOTAL STOCKHOLDERS' DEFICIT	(2,338,200)	1,565,821
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	5,323,435	11,314,395
Convertible Preferred Stock Series B
STOCKHOLDERS' DEFICIT
Preferred stock, $0.0001 par value, 5,000,000 shares authorized;	0	0
Convertible Preferred Stock Series C
STOCKHOLDERS' DEFICIT
Preferred stock, $0.0001 par value, 5,000,000 shares authorized;	$ 50	$ 50